Sign in
4

Changes in Ownership

AbCellera Biologics Inc. Filed Acc 0001628280-26-042739

Options or other derivatives

  • Director acquired 111,701 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Hayden Michael R Director 2026-06-11 Grant or award · Share option (right to buy) +111,701 1,011,544 D
Loading xslF345X06/wk-form4_1781283845.xml…